Patient care squeezed by soaring drug prices
Huff, B.
Gmhc Treatment Issues the Gay Men's Health Crisis Newsletter of Experimental Aids Therapies 16(4): 1-7
2002
ISSN/ISBN: 1077-1824 PMID: 12141256 Document Number: 549818
Document emailed within 1 workday
Related Documents
Orsi, F.; d'almeida, C. 2010: Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries Current Opinion in HIV and Aids 5(3): 237-241Orsi, F.; d'almeida, C. 2010: Soaring antiretroviral prices, TRIPS and TRIPS flexibilities: a burning issue for antiretroviral treatment scale-up in developing countries Current Opinion in HIV and Aids 5(3): 237-241
Holoweiko, M. 1991: Don't get squeezed by a managed-care contract Medical Economics 68(14): 106-108; 110-113
Kirkner, R.M. 2017: To Dent Soaring Drug Costs, States Turn to 'Price-Gouging' Laws Managed Care 26(9): 8-9
Rutten, F.F. 1996: Pharmaco-economics and drug prices Nederlands Tijdschrift Voor Geneeskunde 140(45): 2216-2219
Kelley, T. 2017: Drug Prices: Why So High and Why So #&*! Complicated Managed Care 26(12): 14-16
Goozner, M. 2016: The unaffordable cost of M&A-driven drug prices Modern Healthcare 46(35): 24
Lubell, J. 2010: Out is in; in is out. Reform law lowers drug prices--for outpatient only Modern Healthcare 40(18): 12-13
Weissenstein, E. 1992: Senate proposal would reduce drug prices for federal agencies Modern Healthcare 22(33): 20
Castellucci, M. 2016: Taking the initiative in healthcare: will California voters cap drug prices? Modern Healthcare 46(43): 8; 10
Fong, T. 2004: Rules and regulations. CMS addresses drug prices, payment rates Modern Healthcare 34(31): 8-9 13
Burns, J. 1993: Stocks slide as patient volume, prices fall Modern Healthcare 23(18): 16
Greene, J. 2018: Why drug prices will continue to roil the waters-and why Scott Gottlieb, MD, will be in the center of the action Managed Care 27(12): 23-28
Herman, B. 2015: ACA coverage expansion at risk...battle against high drug prices...growing government business Modern Healthcare 45(1): 20
Rogers, J. 2010: Continence care is going down the pan as costs are cut and prices rise Nursing Times 106(24): 29
Sloane, T. 2006: Healthcare isn't a Chevy. President's drive to list prices for care may crash with reality Modern healthcare 36(9): 18
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Morozova, M.A. 2000: Relative drug resistance as a result of an erroneous approach to patient care Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 100(12): 68-71
Bulkin, W.; Brown, L.; Fraioli, D.; Giannattasio, E.; McGuire, G.; Tyler, P.; Friedland, G. 1988: Hospice care of the intravenous drug user AIDS patient in a skilled nurse facility Journal of Acquired Immune Deficiency Syndromes 1(4): 375-380
Arbab, A.G. 1977: The role of drug information centres for improving patient care in Pakistan and other developing countries Jpma. Journal of the Pakistan Medical Association 27(3): 300-302